NIPT and Informed Consent: an Assessment of Patient Understanding of a Negative NIPT Result

Journal of Genetic Counseling

Volumn 25, Issue 5, 2016, Pages 1127-1137

  Piechan, Julie L ^a   Hines, Karrie A ^b   Koller, Daniel L ^a   Stone, Kristyne ^b   Quaid, Kimberly ^a   Torres Martinez, Wilfredo ^a   Wilson Mathews, Divya ^c   Foroud, Tatiana ^a   Cook, Lola ^c  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b INDIANA UNIVERSITY HEALTH   (United States)

^c ST VINCENT HOSPITAL   (United States)

Author keywords

Cell free fetal DNA; cffDNA; Informed consent; Noninvasive prenatal screening; Noninvasive prenatal testing; Patient education; Patient knowledge

Indexed keywords

ADULT; ANEUPLOIDY; COMPREHENSION; DOWN SYNDROME; FEMALE; FETUS; GENETICS; HUMAN; INFORMED CONSENT; MALE; PARENT; PREGNANCY; PRENATAL DIAGNOSIS; PSYCHOLOGY; QUESTIONNAIRE; YOUNG ADULT;

ADULT; ANEUPLOIDY; COMPREHENSION; DOWN SYNDROME; FEMALE; FETUS; HUMANS; INFORMED CONSENT; MALE; PARENTS; PREGNANCY; PRENATAL DIAGNOSIS; SURVEYS AND QUESTIONNAIRES; YOUNG ADULT;

EID: 84962177644     PISSN: 10597700     EISSN: 15733599     Source Type: Journal    
DOI: 10.1007/s10897-016-9945-x     Document Type: Article

References (42)

1. ACOG. (2007). Practice Bulletin No. 77: screening for fetal chromosomal abnormalities. Obstetrics & Gynecology, 109, 217–227.
2. ACOG. (2012). Noninvasive prenatal testing for fetal aneuploidy. Committee Opinion No. 545. Obstetrics & Gynecology, 120, 1532–1534.
3. ACOG. (2015). Cell-free DNA screening for fetal aneuploidy. Committee Opinion No. 640. Obstetrics & Gynecology, 126(3), e31–e37.
4. Agatisa, P. K., Mercer, M. B., Leek, A. C., Smith, M. B., Philipson, E., & Farrell, R. M. (2015). A first look at women’s perspectives on noninvasive prenatal testing to detect sex chromosome aneuploidies and microdeletion syndromes. Prenatal Diagnosis, 35(7), 692–698.
5. Ames, A. G., Metcalfe, S. A., Dalton Archibald, A., Duncan, R. E., & Emery, J. (2015). Measuring informed choice in population-based reproductive genetic screening: a systematic review. European Journal of Human Genetics, 23(1), 8–21.
6. Benn, P., Cuckle, H., & Pergament, E. (2013). Non-invasive prenatal testing for aneuploidy: current status and future prospects. Ultrasound in Obstetrics & Gynecology, 42, 15–33.
7. Bianchi, D. W., & Wilkins-Haug, L. (2014). Integration of noninvasive DNA testing for aneuploidy into prenatal care: what has happened since the rubber met the road? Clinical Chemistry, 60(1), 78–87.
8. Bryant, A. S., Norton, M. E., Nakagawa, S., Bishop, J. T., Pena, S., Gregorich, S. E., & Kuppermann, M. (2015). Variation in women’s understanding of prenatal testing. Obstetrics & Gynecology, 125(6), 1306–1312.
9. Buchanan, A., Sachs, A., Toler, T., & Tsipis, J. (2014). NIPT: current utilization and implications for the future of prenatal genetic counseling. Prenatal Diagnosis, 34, 850–857.
10. Cho, R. N., Plunkett, B. A., Wolf, M. S., Simon, C. E., & Grobman, W. A. (2007). Health literacy and patient understanding of screening tests for aneuploidy and neural tube defects. Prenatal Diagnosis, 27(5), 463–467.
11. Devers, P. L., Cronister, A., Ormond, K. E., Facio, F., Brasington, C. K., & Flodman, P. (2013). Noninvasive prenatal testing/noninvasive prenatal diagnosis: the position of the national society of genetic counselors. Journal of Genetic Counseling, 22, 291–295.
12. Dickens, B. M. (2013). Ethical and legal aspects of noninvasive prenatal genetic diagnosis. International Journal of Gynecology & Obstetrics, 124, 181–184.
13. Dormandy, E., Michie, S., Hooper, R., & Marteau, T. M. (2006). Informed choice in antenatal Down syndrome screening: a cluster-randomized trial of combined versus separate visit teaching. Patient Education and Counseling, 61(1), 56–64.
14. Farrell, R., Hawkins, A., Barragan, D., Hudgins, L., & Taylor, J. (2015). Knowledge, understanding, and uptake of noninvasive prenatal testing among Latina women. Prenatal Diagnosis, 35(8), 748–753.
15. Glazier, R., Goel, V., Holzapfel, S., Summers, A., Pugh, P., & Yeung, M. (1997). Written patient information about triple-marker screening: a randomized, controlled trial. Obstetrics and Gynecology, 90(5), 769–774.
16. Goel, V., Glazier, R., Holzapfel, S., Pugh, P., & Summers, A. (1996). Evaluating patient’s knowledge of maternal serum screening. Prenatal Diagnosis, 16, 425–430.
17. Gourounti, K., & Sandall, J. (2008). Do pregnant women in Greece make informed choices about antenatal screening for down’s syndrome? A questionnaire survey. Midwifery, 24(2), 153–162.
18. Gregg, A. R., Gross, S. J., Best, R. G., Monaghan, K. G., Bajaj, K., Skotko, B. G., et al. (2013). ACMG statement on noninvasive prenatal screening for fetal aneuploidy. Genetics in Medicine, 15(5), 395–398.
19. Harris, P. A., Taylor, R., Thielke, R., Payne, J., Gonzalez, N., & Conde, J. G. (2009). Research electronic data capture (REDCap) - A metadata-driven methodology and workflow process for providing translational research informatics support. Journal of Biomedical Informatics, 42(2), 377–381.
20. Jong, A. D., Maya, I., & Van Lith, J. M. M. (2015). Prenatal screening: current practice, new developments, ethical challenges. Bioethics, 29(1), 1–8.
21. Kohut, R. J., Dewey, D., & Love, E. J. (2002). Women’s knowledge of prenatal ultrasound and informed choice. Journal of Genetic Counseling, 11(4), 265–276.
22. Kuppermann, M., Pena, S., Bishop, J. T., Nakagawa, S., Gregorich, S. E., Sit, A., et al. (2014). Effect of enhanced information, values clarification, and removal of financial barriers on use of prenatal genetic testing: a randomized clinical trial. JAMA, 312(12), 1210–1217.
23. Lewis, C., Slicock, C., & Chitty, L. S. (2013). Non-invasive prenatal testing for Down’s syndrome: pregnant women’s views and likely uptake. Public Health Genomics, 16, 223–232.
24. Lewis, C., Hill, M., Skirton, H. & Chitty, L.S. (2015). Development and validation of a measure of informed choice for women undergoing non-invasive prenatal testing for aneuploidy. European Journal of Human Genetics.
25. Lo, Y. M. D., Corbetta, N., Chamberlain, P. F., Rai, V., Sargent, I. L., Redman, C. W. G., et al. (1997). Presence of fetal DNA in maternal plasma and serum. The Lancet, 350, 485–487.
26. Lo, J. O., Feist, C. D., Norton, M. E., & Caughey, A. B. (2014). Noninvasive prenatal testing. Obstetrical & Gynecological Survey, 69(2), 89–99.
27. Marteau, T. M., Dormandy, E., & Michie, S. (2001). A measure of informed choice. Health Expectations, 4(2), 99–108.
28. Mercer, M. B., Agatisa, P. K., & Farrell, R. M. (2014). What patients are reading about noninvasive prenatal testing: and evaluation of Internet content and implications for patient-centered care. Prenatal Diagnosis, 34, 986–993.
29. Nicolaides, K. H., Syngelaki, A., Gil, M., Atanasova, V., & Markova, D. (2013). Validating of targeted sequencing of single-nucleotide polymorphisms for non-invasive prenatal detection of aneuploidy of chromosomes 13, 18, 21, X, and Y. Prenatal Diagnosis, 33, 575–579.
30. Norton, M. E., & Rink, B. D. (2016). Changing indications for invasive testing in an eral of improved screening. Seminars in Perinatology, 40(1), 56–66.
31. Norton, M. E., Brar, H., Weiss, J., Karimi, A., Laurent, L. C., Caughey, A. B., et al. (2012). Non-Invasive Chromosomal Evaluation (NICE) Study: results of a multicenter prospective cohort study for detection of fetal trisomy 21 and trisomy 18. American Journal of Obstetrics & Gynecology, 207, 137e1Y137e8.
32. Norton, M. E., Rose, N. C., & Benn, P. (2013). Noninvasive prenatal testing for fetal aneuploidy: clinical assessment and a plea for restraint. Obstetrics & Gynecology, 121(4), 847–850.
33. Patton, M. Q. (2001). Qualitative evaluation and research methods (p. 2001). Thousand Oaks: Sage.
34. Pettit, K., Hull, A. D., Korty, L., Jones, M. C., & Pretorius, D. H. (2014). The utilization of circulating cell-free fetal DNA testing and decreases in invasive diagnostic procedures: an institutional experience. Journal of Perinatology, 34(10), 750–753.
35. Rink, B. D., & Norton, M. E. (2016). Screening for fetal aneupoidy. Seminars in Perinatology, 40(1), 35–43.
36. Robinson, C., Van Den Boom, D., & Bombard, A. T. (2014). Noninvasive prenatal detection of aneuploidy. Clinical Obstetrics and Gynecology, 57(1), 210–225.
37. Rowe, H. J., Fisher, J. R., & Quinlivan, J. A. (2006). Are pregnant Australian women well informed about prenatal genetic screening? A systematic investigation using the multidimensional measure of informed choice. The Australian & New Zealand Journal of Obstetrics & Gynaecology, 46(5), 433–439.
38. Swaney, P., Hardisty, E., Sayres, L., Wiegand, S., & Vora, N. (2016). Attitudes and knowledge of maternal fetal medicine fellows regarding noninvase prentatal testing. Journal of Genetic Counseling, 25(1), 73–78.
39. van den Bergh, M., Timmermans, D. R., ten Kate, L. P., van Vugt, J. M. G., & van der Wal, G. (2005). Are pregnant women making informed choices about prenatal screening? Genetics in Medicine: Official Journal of the American College of Medical Genetics, 7(5), 332–338.
40. Wagner, A. J., Mitchell, M. E., & Tomita-Mitchell, A. (2014). Use of cell-free fetal DNA in Maternal plasma for noninvasive prenatal screening. Clinical Perinatology, 41, 957–966.
41. Wax, J. R., Cartin, A., Chard, R., Lucas, F. L., & Pinette, M. G. (2014). Noninvasive prenatal testing: impact on genetic counseling, invasive prenatal diagnosis, and trisomy 21 detection. Journal of Clinical Ultrasound, 43(1), 1–6.
42. Yee, L. M., Wolf, M., Mullen, R., Bergeron, A. R., Bailey, S. C., Levine, R., et al. (2014). A randomized trial of a prenatal genetic testing interactive computerized information aid. Prenatal Diagnosis, 34(6), 552–557.